You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Pancytopenia After Allogeneic Bone Marrow Transplant Due to Copper Deficiency

Hudspeth, Michelle MD; Turner, Amy BSN; Miller, Nicole MD; Lazarchick, John MD

Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e318290c644
Clinical and Laboratory Observations

Pancytopenia occurring 1 year or later after allogeneic bone marrow transplantation typically prompts a primary consideration for relapse. We present the case of a 15-year old-girl who underwent transplantation for therapy-related myelodysplasia secondary to Ewing sarcoma treatment who developed pancytopenia with myelodysplasia 1 year after transplant due to copper deficiency. Copper deficiency is an important consideration in the evaluation of pancytopenia and myelodysplasia in pediatric patients.

Author Information

*Department of Pediatrics, Division of Pediatric Hematology/Oncology

College of Medicine

Department of Pathology, Medical University of South Carolina, Charleston, SC

The authors declare no conflict of interest.

Reprints: Michelle Hudspeth, MD, Department of Pediatrics, Division of Pediatric Hematology/Oncology, Medical University of South Carolina, 135 Rutledge Ave., MSC 558, Charleston, SC 29425 (e-mail:

Received October 1, 2012

Accepted March 2, 2013

Copyright © 2014 Wolters Kluwer Health, Inc. All rights reserved.